NASDAQ:CELU
Celularity Inc
Celularity Inc's revenue fell 51.0% in fiscal 2025 to $26.6M while operating margin fell to −230.9%. The diluted share count rose 16.9%.Summary generated from Celularity Inc's SEC filings. Latest annual report filed Apr 30, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$26.6M
Revenue growth−51.0%
Revenue, 5-yr CAGR+13.2%
Gross margin24.4%
Operating margin−230.9%
Net margin−345.4%
ROICn/a
Return on equityn/a
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+16.9%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 21 | 18 | 23 | 54 | 27 |
| Operating income | −109 | −26 | −192 | −38 | −61 |
| Net income | −100 | 14 | −196 | −58 | −92 |
| Free cash flow | −116 | −143 | −40 | −7 | n/a |
Recent filings
- 8-KDirector or officer change
Sep 29, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
Sep 29, 2026 - 8-KEntry into a material agreement
Sep 28, 2026 - 4Insider transaction report
Sep 25, 2026 - 4Insider transaction report
Sep 25, 2026 - 8-KOther events
Sep 14, 2026 - 8-KDirector or officer change
Aug 7, 2026 - 8-KNotice of delisting or listing-rule failure
Jul 29, 2026